Pettiti Gianluca, an insider at Thermo Fisher Scientific Inc (TMO), executed a sale of 21,152 shares on November 9, 2025, at a price of $580.00 per share, amounting to a total transaction value of $12.27 million. Following this transaction, Gianluca retains 21,152 shares in the company.
Such decisions reflect a range of motivations, including personal financial planning, diversification, or tax considerations. While significant insider sales can attract attention, they do not inherently signal negative sentiment toward the company. Investors are encouraged to consider insider transactions as just one aspect of a broader analysis, alongside other fundamental and technical indicators.
Thermo Fisher Scientific, headquartered in Waltham, Massachusetts, operates in the Life Sciences Tools & Services industry. The company employs 125,000 full-time staff and provides a comprehensive portfolio of innovative products and services for the scientific community. Its offerings span reagents, instruments, and consumables for biological and medical research, drug discovery, and diagnostic applications.
As of November 13, 2025, Thermo Fisher boasts a market capitalization of $223.4 billion, a P/E ratio of 34.03, and an EPS of 17.30. The company also maintains a dividend yield of 29.3%. Upcoming earnings are scheduled for April 20, 2026, with an estimated EPS of $5.64 and revenue of $11.1 billion, followed by another report on July 20, 2026, projecting an EPS of $5.93 and revenue of $11.5 billion.